Evidence map›Paper›PMID 27896377›Full record

ArticlePsychopharmacology2017

Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.

S L Huskinson, J E Naylor, E A Townsend, J K Rowlett, B E Blough, K B Freeman

Abstract read
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Neuropsychopharmacology of Emerging Drugs of Abuse:International journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
  11. Reinforcing and Stimulant-Like Effects of Methamphetamine Isomers in Rhesus Macaques.The Journal of pharmacology and experimental therapeutics · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S L HuskinsonDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA. shuskinson@umc.edu.
J E NaylorProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS, 39216, USA.
E A TownsendProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS, 39216, USA.
J K RowlettDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA.
B E BloughCenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, 27709, USA.
K B FreemanDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA.

Funding

ANXIOLYTIC EFFECTS AND ABUSE OF BZ RECEPTOR LIGANDSR01DA011792 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROWLETT, JAMES K · 1998 to 2024
$7.8M
POTENTIAL TREATMENT MEDICATIONS FOR DRUG ABUSER01DA012970 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI BLOUGH, BRUCE E · 1999 to 2013
$5.5M
Deterrents for prescription opioid abuseR01DA039167 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI FREEMAN, KEVIN B. · 2015 to 2025
$4.9M
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedationR01DA033795 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROWLETT, JAMES K · 2012 to 2016
$2.4M
Delay Discounting and the Choice to Take a DrugR01DA027666 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI FREEMAN, KEVIN B. · 2010 to 2014
$1.4M
Unpredictable drug and non-drug alternatives as determinants of cocaine choiceF32DA037619 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI HUSKINSON, SALLY · 2014 to 2016
$169k
NIDA NIH HHS F32 DA037619NIDA NIH HHS R01 DA011792NIDA NIH HHS R01 DA012970NIDA NIH HHS R01 DA027666NIDA NIH HHS R01 DA033795NIDA NIH HHS R01 DA039167
6 · The paper itself

Abstract

rationaleSynthetic cathinones have become increasingly available as drugs of abuse. Distribution of these drugs is made possible by altering the chemical structures of prohibited cathinones and marketing them under misleading labels. Very little is known about the relative reinforcing effectiveness of new synthetic cathinones relative to known drugs of abuse.

objectiveWe examined self-administration of three second-generation synthetic cathinones: alpha-pyrrolidinopentiophenone (alpha-PVP), 4-methyl-N-ethylcathinone (4-MEC), and 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) relative to methamphetamine.

methodMale, Sprague-Dawley rats, implanted with intravenous catheters, were trained to self-administer methamphetamine (0.05 mg/kg/injection) under a fixed-ratio schedule. Following training, various doses of methamphetamine (0.006-0.1 mg/kg/injection), alpha-PVP (0.0015-0.1 mg/kg/injection), 4-MEC (0.1-3.2 mg/kg/injection), or 4-MePPP (0.1-0.8 mg/kg/injection) were available for self-administration in separate groups, followed by a behavioral-economics evaluation of the reinforcing effectiveness of each drug.

resultsFor all drugs, at least one dose functioned as a reinforcer. Alpha-PVP and 4-MePPP maintained the highest numbers of infusions per session and both were more effective reinforcers relative to methamphetamine. 4-MEC and methamphetamine were not significantly different in terms of infusions per session or reinforcing effectiveness.

conclusionEmerging synthetic cathinones whose primary pharmacological mechanism is to block dopamine uptake but with little effects on monoamine release or serotonin uptake may have a greater degree of abuse potential compared with known abused stimulants.

Indexed as

AmphetaminesAnimalsCentral Nervous System StimulantsDose-Response Relationship, DrugEconomics, BehavioralIllicit DrugsMaleMethamphetaminePentanonesPropiophenonesPyrrolesPyrrolidinesRatsRats, Sprague-DawleyReinforcement, PsychologySelf Administration1-phenyl-2-(1-pyrrolidinyl)-1-pentanone4'-methyl-alpha-pyrrolidinopropiophenone4-methylethcathinoneAmphetaminesCentral Nervous System StimulantsIllicit DrugsMethamphetaminePentanonesPropiophenonesPyrrolesPyrrolidines4-methyl-N-ethylcathinone (4-MEC)4-methyl-α-pyrrolidinopropiophenone (4-MePPP)alpha-pyrrolidinopentiophenone (alpha-PVP)MethamphetamineSelf-administrationSynthetic cathinone

Identifiers

PMID27896377
PMCPMC5266647

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.